Asthma Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Short-Acting Beta-Agonists (SABA), Long-Acting Beta-Agonists (LABA), Inhaled Corticosteroids (ICS), Leukotriene Modifiers, Immunomodulators, Combination Drugs, Others), By Mode of Administration (Inhalers, Nebulizers, Oral Medications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Region and Competition, 2020-2030F
The Global Asthma Treatment Market was valued at USD 27.84 billion in 2024 and is projected t%li%reach USD 36.47 billion by 2030, growing at a CAGR of 4.58% during the forecast period. The market is expanding due t%li%the rising prevalence of asthma, increased healthcare investment, and growing R&D initiatives focused on advanced therapeutics. Asthma remains a major public health concern globally, particularly in countries like the United States, where its burden has created significant demand for effective treatments. Technological innovations in drug delivery systems—such as smart inhalers and nebulizers—and the growing availability of biologic therapies are transforming asthma management. Biologic treatments offer targeted intervention for severe cases, improving outcomes and reducing hospitalizations. These advancements, along with the focus on patient-centric and precision medicine, are expected t%li%drive continued growth in the global asthma treatment landscape.
Key Market Drivers
Increasing Investment in Research and Development
Substantial investment in R&D is a key driver of innovation in the asthma treatment market. With asthma being a complex, chronic condition, pharmaceutical companies and health organizations are prioritizing the development of new drugs and therapies t%li%meet unmet needs. In the U.S., the National Institutes of Health (NIH) allocates over USD 100 million annually for asthma research, supporting advancements in diagnostics, treatment modalities, and prevention strategies. These investments contribute t%li%breakthroughs in biologics, combination therapies, and personalized medicine approaches that enhance treatment effectiveness and patient outcomes. Furthermore, advancements in drug delivery devices and digital health solutions are improving disease monitoring and self-management.
Key Market Challenges
High Cost of Advanced Therapies
A major barrier in the global asthma treatment market is the high cost of biologic therapies used t%li%treat severe asthma. These treatments, such as monoclonal antibodies, can cost thousands of dollars annually per patient, limiting access in low- and middle-income countries and placing strain on healthcare budgets even in developed regions. Limited insurance coverage and inconsistent reimbursement policies further exacerbate this issue, often resulting in delays or non-adherence t%li%prescribed therapies. While biologics are effective, the associated costs can hinder widespread adoption, and addressing this financial barrier will be crucial for equitable access t%li%advanced asthma treatments.
Key Market Trends
Integration of Digital Health Technologies
The increasing integration of digital technologies is reshaping asthma management. Tools such as mobile apps, wearable devices, and smart inhalers are enabling patients t%li%track symptoms, monitor environmental triggers, and ensure medication adherence in real time. Smart inhalers equipped with sensors send usage data t%li%connected devices, allowing both patients and healthcare providers t%li%assess therapy effectiveness and make timely adjustments. These innovations support personalized asthma management, reduce flare-ups, and decrease hospital visits. As healthcare moves toward remote monitoring and data-driven decision-making, digital health technologies are expected t%li%play a central role in asthma care delivery.
Key Market Players
In this report, the Global Asthma Treatment Market has been segmented int%li%the following categories, in addition t%li%the industry trends which have als%li%been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Asthma Treatment Market.
Available Customizations:
Global Asthma Treatment Market report with the given market data, TechSci Research offers customizations according t%li%a company's specific needs. The following customization options are available for the report:
Company Information
Key Market Drivers
Increasing Investment in Research and Development
Substantial investment in R&D is a key driver of innovation in the asthma treatment market. With asthma being a complex, chronic condition, pharmaceutical companies and health organizations are prioritizing the development of new drugs and therapies t%li%meet unmet needs. In the U.S., the National Institutes of Health (NIH) allocates over USD 100 million annually for asthma research, supporting advancements in diagnostics, treatment modalities, and prevention strategies. These investments contribute t%li%breakthroughs in biologics, combination therapies, and personalized medicine approaches that enhance treatment effectiveness and patient outcomes. Furthermore, advancements in drug delivery devices and digital health solutions are improving disease monitoring and self-management.
Key Market Challenges
High Cost of Advanced Therapies
A major barrier in the global asthma treatment market is the high cost of biologic therapies used t%li%treat severe asthma. These treatments, such as monoclonal antibodies, can cost thousands of dollars annually per patient, limiting access in low- and middle-income countries and placing strain on healthcare budgets even in developed regions. Limited insurance coverage and inconsistent reimbursement policies further exacerbate this issue, often resulting in delays or non-adherence t%li%prescribed therapies. While biologics are effective, the associated costs can hinder widespread adoption, and addressing this financial barrier will be crucial for equitable access t%li%advanced asthma treatments.
Key Market Trends
Integration of Digital Health Technologies
The increasing integration of digital technologies is reshaping asthma management. Tools such as mobile apps, wearable devices, and smart inhalers are enabling patients t%li%track symptoms, monitor environmental triggers, and ensure medication adherence in real time. Smart inhalers equipped with sensors send usage data t%li%connected devices, allowing both patients and healthcare providers t%li%assess therapy effectiveness and make timely adjustments. These innovations support personalized asthma management, reduce flare-ups, and decrease hospital visits. As healthcare moves toward remote monitoring and data-driven decision-making, digital health technologies are expected t%li%play a central role in asthma care delivery.
Key Market Players
- GlaxoSmithKline, Plc
- AstraZeneca Plc
- Teva Pharmaceutical Industries Ltd.
- Boehringer Ingelheim GmbH
- Merck & Co. Inc.
- Novartis AG
- Sanofi SA
- Roche Holding AG
- Regeneron Pharmaceutical Inc.
- Pfizer Inc.
In this report, the Global Asthma Treatment Market has been segmented int%li%the following categories, in addition t%li%the industry trends which have als%li%been detailed below:
- Asthma Treatment Market, By Drug Class:
- Short-Acting Beta-Agonists (SABA)
- Long-Acting Beta-Agonists (LABA)
- Inhaled Corticosteroids (ICS)
- Leukotriene Modifiers
- Immunomodulators
- Combination Drugs
- Others
- Asthma Treatment Market, By Mode of Administration:
- Inhalers
- Nebulizers
- Oral Medications
- Asthma Treatment Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Asthma Treatment Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in the Global Asthma Treatment Market.
Available Customizations:
Global Asthma Treatment Market report with the given market data, TechSci Research offers customizations according t%li%a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up t%li%five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. VOICE OF CUSTOMER
5. GLOBAL ASTHMA TREATMENT MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Drug Class (Short-Acting Beta-Agonists (SABA), Long-Acting Beta-Agonists (LABA), Inhaled Corticosteroids (ICS), Leukotriene Modifiers, Immunomodulators, Combination Drugs, Others)
5.2.2. By Mode of Administration (Inhalers, Nebulizers, Oral Medications)
5.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others)
5.2.4. By Company (2024)
5.2.5. By Region
5.3. Market Map
6. NORTH AMERICA ASTHMA TREATMENT MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Class
6.2.2. By Mode of Administration
6.2.3. By Distribution Channel
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Asthma Treatment Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Drug Class
6.3.1.2.2. By Mode of Administration
6.3.1.2.3. By Distribution Channel
6.3.2. Mexico Asthma Treatment Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Drug Class
6.3.2.2.2. By Mode of Administration
6.3.2.2.3. By Distribution Channel
6.3.3. Canada Asthma Treatment Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Drug Class
6.3.3.2.2. By Mode of Administration
6.3.3.2.3. By Distribution Channel
7. EUROPE ASTHMA TREATMENT MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Class
7.2.2. By Mode of Administration
7.2.3. By Distribution Channel
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Asthma Treatment Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drug Class
7.3.1.2.2. By Mode of Administration
7.3.1.2.3. By Distribution Channel
7.3.2. Germany Asthma Treatment Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drug Class
7.3.2.2.2. By Mode of Administration
7.3.2.2.3. By Distribution Channel
7.3.3. United Kingdom Asthma Treatment Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drug Class
7.3.3.2.2. By Mode of Administration
7.3.3.2.3. By Distribution Channel
7.3.4. Italy Asthma Treatment Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Drug Class
7.3.4.2.2. By Mode of Administration
7.3.4.2.3. By Distribution Channel
7.3.5. Spain Asthma Treatment Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Drug Class
7.3.5.2.2. By Mode of Administration
7.3.5.2.3. By Distribution Channel
8. ASIA-PACIFIC ASTHMA TREATMENT MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Class
8.2.2. By Mode of Administration
8.2.3. By Distribution Channel
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Asthma Treatment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drug Class
8.3.1.2.2. By Mode of Administration
8.3.1.2.3. By Distribution Channel
8.3.2. India Asthma Treatment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drug Class
8.3.2.2.2. By Mode of Administration
8.3.2.2.3. By Distribution Channel
8.3.3. South Korea Asthma Treatment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Drug Class
8.3.3.2.2. By Mode of Administration
8.3.3.2.3. By Distribution Channel
8.3.4. Japan Asthma Treatment Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Drug Class
8.3.4.2.2. By Mode of Administration
8.3.4.2.3. By Distribution Channel
8.3.5. Australia Asthma Treatment Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Drug Class
8.3.5.2.2. By Mode of Administration
8.3.5.2.3. By Distribution Channel
9. SOUTH AMERICA ASTHMA TREATMENT MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Class
9.2.2. By Mode of Administration
9.2.3. By Distribution Channel
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Asthma Treatment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Drug Class
9.3.1.2.2. By Mode of Administration
9.3.1.2.3. By Distribution Channel
9.3.2. Argentina Asthma Treatment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Drug Class
9.3.2.2.2. By Mode of Administration
9.3.2.2.3. By Distribution Channel
9.3.3. Colombia Asthma Treatment Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Drug Class
9.3.3.2.2. By Mode of Administration
9.3.3.2.3. By Distribution Channel
10. MIDDLE EAST AND AFRICA ASTHMA TREATMENT MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Drug Class
10.2.2. By Mode of Administration
10.2.3. By Distribution Channel
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Asthma Treatment Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Drug Class
10.3.1.2.2. By Mode of Administration
10.3.1.2.3. By Distribution Channel
10.3.2. Saudi Arabia Asthma Treatment Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Drug Class
10.3.2.2.2. By Mode of Administration
10.3.2.2.3. By Distribution Channel
10.3.3. UAE Asthma Treatment Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Drug Class
10.3.3.2.2. By Mode of Administration
10.3.3.2.3. By Distribution Channel
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. PORTERS FIVE FORCES ANALYSIS
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. COMPETITIVE LANDSCAPE
14.1. GlaxoSmithKline, Plc
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (As Reported)
14.1.5. Recent Developments
14.1.6. Key Personnel Details
14.1.7. SWOT Analysis
14.2. AstraZeneca Plc
14.3. Teva Pharmaceutical Industries Ltd.
14.4. Boehringer Ingelheim Gmbh
14.5. Merck & Co. Inc.
14.6. Novartis AG
14.7. Sanofi SA
14.8. Roche Holding AG
14.9. Regeneron Pharmaceutical Inc.
14.10. Pfizer Inc.
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. VOICE OF CUSTOMER
5. GLOBAL ASTHMA TREATMENT MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Drug Class (Short-Acting Beta-Agonists (SABA), Long-Acting Beta-Agonists (LABA), Inhaled Corticosteroids (ICS), Leukotriene Modifiers, Immunomodulators, Combination Drugs, Others)
5.2.2. By Mode of Administration (Inhalers, Nebulizers, Oral Medications)
5.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others)
5.2.4. By Company (2024)
5.2.5. By Region
5.3. Market Map
6. NORTH AMERICA ASTHMA TREATMENT MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Class
6.2.2. By Mode of Administration
6.2.3. By Distribution Channel
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Asthma Treatment Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Drug Class
6.3.1.2.2. By Mode of Administration
6.3.1.2.3. By Distribution Channel
6.3.2. Mexico Asthma Treatment Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Drug Class
6.3.2.2.2. By Mode of Administration
6.3.2.2.3. By Distribution Channel
6.3.3. Canada Asthma Treatment Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Drug Class
6.3.3.2.2. By Mode of Administration
6.3.3.2.3. By Distribution Channel
7. EUROPE ASTHMA TREATMENT MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Class
7.2.2. By Mode of Administration
7.2.3. By Distribution Channel
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Asthma Treatment Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drug Class
7.3.1.2.2. By Mode of Administration
7.3.1.2.3. By Distribution Channel
7.3.2. Germany Asthma Treatment Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drug Class
7.3.2.2.2. By Mode of Administration
7.3.2.2.3. By Distribution Channel
7.3.3. United Kingdom Asthma Treatment Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drug Class
7.3.3.2.2. By Mode of Administration
7.3.3.2.3. By Distribution Channel
7.3.4. Italy Asthma Treatment Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Drug Class
7.3.4.2.2. By Mode of Administration
7.3.4.2.3. By Distribution Channel
7.3.5. Spain Asthma Treatment Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Drug Class
7.3.5.2.2. By Mode of Administration
7.3.5.2.3. By Distribution Channel
8. ASIA-PACIFIC ASTHMA TREATMENT MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Class
8.2.2. By Mode of Administration
8.2.3. By Distribution Channel
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Asthma Treatment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drug Class
8.3.1.2.2. By Mode of Administration
8.3.1.2.3. By Distribution Channel
8.3.2. India Asthma Treatment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drug Class
8.3.2.2.2. By Mode of Administration
8.3.2.2.3. By Distribution Channel
8.3.3. South Korea Asthma Treatment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Drug Class
8.3.3.2.2. By Mode of Administration
8.3.3.2.3. By Distribution Channel
8.3.4. Japan Asthma Treatment Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Drug Class
8.3.4.2.2. By Mode of Administration
8.3.4.2.3. By Distribution Channel
8.3.5. Australia Asthma Treatment Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Drug Class
8.3.5.2.2. By Mode of Administration
8.3.5.2.3. By Distribution Channel
9. SOUTH AMERICA ASTHMA TREATMENT MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Class
9.2.2. By Mode of Administration
9.2.3. By Distribution Channel
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Asthma Treatment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Drug Class
9.3.1.2.2. By Mode of Administration
9.3.1.2.3. By Distribution Channel
9.3.2. Argentina Asthma Treatment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Drug Class
9.3.2.2.2. By Mode of Administration
9.3.2.2.3. By Distribution Channel
9.3.3. Colombia Asthma Treatment Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Drug Class
9.3.3.2.2. By Mode of Administration
9.3.3.2.3. By Distribution Channel
10. MIDDLE EAST AND AFRICA ASTHMA TREATMENT MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Drug Class
10.2.2. By Mode of Administration
10.2.3. By Distribution Channel
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Asthma Treatment Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Drug Class
10.3.1.2.2. By Mode of Administration
10.3.1.2.3. By Distribution Channel
10.3.2. Saudi Arabia Asthma Treatment Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Drug Class
10.3.2.2.2. By Mode of Administration
10.3.2.2.3. By Distribution Channel
10.3.3. UAE Asthma Treatment Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Drug Class
10.3.3.2.2. By Mode of Administration
10.3.3.2.3. By Distribution Channel
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. PORTERS FIVE FORCES ANALYSIS
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. COMPETITIVE LANDSCAPE
14.1. GlaxoSmithKline, Plc
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (As Reported)
14.1.5. Recent Developments
14.1.6. Key Personnel Details
14.1.7. SWOT Analysis
14.2. AstraZeneca Plc
14.3. Teva Pharmaceutical Industries Ltd.
14.4. Boehringer Ingelheim Gmbh
14.5. Merck & Co. Inc.
14.6. Novartis AG
14.7. Sanofi SA
14.8. Roche Holding AG
14.9. Regeneron Pharmaceutical Inc.
14.10. Pfizer Inc.
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
